Loading insider details...
Beta
Latest Form 4 (Mar 13, 2026): Grant/Award of 20,000 ENTA shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Mar 13, 2026 | ENANTA PHARMACEUTICALS INC (ENTA) | Grant/Award | 20,000 | n/a |
| Mar 14, 2025 | ENANTA PHARMACEUTICALS INC (ENTA) | Grant/Award | 15,700 | n/a |
| Mar 8, 2024 | ENANTA PHARMACEUTICALS INC (ENTA) | Grant/Award | 15,700 | n/a |
| Dec 16, 2023 | ENANTA PHARMACEUTICALS INC (ENTA) | Sale | 15,295 | $139.5K |
| Mar 17, 2023 | ENANTA PHARMACEUTICALS INC (ENTA) | Exercise/Conversion | 5,800 | $81.2K |
| Mar 6, 2023 | ENANTA PHARMACEUTICALS INC (ENTA) | Grant/Award | 10,800 | n/a |
| Mar 7, 2022 | ENANTA PHARMACEUTICALS INC (ENTA) | Grant/Award | 7,500 | n/a |
| Mar 4, 2021 | ENANTA PHARMACEUTICALS INC (ENTA) | Grant/Award | 7,500 | n/a |
| Feb 28, 2020 | ENANTA PHARMACEUTICALS INC (ENTA) | Grant/Award | 10,000 | n/a |